Strategic Delay Backfires: How Novartis Lost Its Cross-Examination Rights
Recently, the DHC disposed of Novartis’ writ petition against the Controller’s orders to continue the post-grant opposition before allowing Novartis to cross-examine the Opponents’ experts. Anushka Kanabar breaks down the judgment, discusses how Novartis’ strategy backfired, and explains why the Controller’s decision does not violate the principles of natural justice. Anushka is a fourth-year B.A., LL.B. (Hons.) student at the National Law School of India University. Her previous posts can be accessed here. Strategic Delay Backfires: How Novartis Lost Its Cross-Examination […]
Strategic Delay Backfires: How Novartis Lost Its Cross-Examination Rights Read More »










